SpaceX, which provides reusable rockets for space travel, global satellite internet, and AI models, announced terms for its IPO on Wednesday. The Starbase, TX-based company plans to raise $75.0 billion by offering 555.6 million shares at $135 per share. At the ...read more
Parabilis Medicines, a clinical-stage biotech developing engineered peptide therapies for cancer, announced terms for its IPO on Wednesday. The Cambridge, MA-based company plans to raise $450 million by offering 25 million shares at a price range of $17 to $19....read more
Gores Holdings XI, a blank check company formed by The Gores Group, filed on Wednesday with the SEC to raise up to $312 million in an initial public offering. The company plans to raise $312 million by offering 31.2 million units at $10. Each unit consists of ...read more
SpaceX sets terms for record-breaking $75 billion IPO
SpaceX, which provides reusable rockets for space travel, global satellite internet, and AI models, announced terms for its IPO on Wednesday. The Starbase, TX-based company plans to raise $75.0 billion by offering 555.6 million shares at $135 per share. At the ...read more
Cancer biotech Parabilis Medicines sets terms for $450 million IPO
Parabilis Medicines, a clinical-stage biotech developing engineered peptide therapies for cancer, announced terms for its IPO on Wednesday. The Cambridge, MA-based company plans to raise $450 million by offering 25 million shares at a price range of $17 to $19....read more
The Gores Group's SPAC Gores Holdings XI files for a $312 million IPO
Gores Holdings XI, a blank check company formed by The Gores Group, filed on Wednesday with the SEC to raise up to $312 million in an initial public offering. The company plans to raise $312 million by offering 31.2 million units at $10. Each unit consists of ...read more